Início › Câncer de Próstata › Nebraska
Ensaios clínicos de Câncer de Próstata em Nebraska
27 estudos para Câncer de Próstata estão buscando participantes em locais em Nebraska.
Cidades em Nebraska
Texto oficial do estudo (Inglês)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- CHI Health Saint Francis, Grand Island
- CHI Health Good Samaritan, Kearney
- Alegent Health Immanuel Medical Center, Omaha
- e mais 2
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05334069Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Nebraska Medicine-Bellevue, Bellevue
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT03866382Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
- Urology Cancer Center, PC, Omaha
RecrutandoFase 1/2
Idades 18 e acima · Homens · Atualizado em 25 de set. de 2026 · NCT06800313A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Oncology Hematology West P.C. dba Nebraska Cancer Specialists ( Site 0026), Omaha
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06136650Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Nebraska Cancer Specialists, Omaha
RecrutandoFase 2/3
Idades de 18 a 100 · Homens · Atualizado em 22 de set. de 2026 · NCT06780670Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- Nebraska Cancer Specialists, Omaha
RecrutandoFase 3
Idades de 18 a 100 · Homens · Atualizado em 22 de set. de 2026 · NCT06855277PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer
- University of Nebraska Medical Center, Omaha
RecrutandoFase 2
Idades 30 e acima · Homens · Atualizado em 21 de set. de 2026 · NCT07234981A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
- XCancer, Omaha
RecrutandoFase 1
Idades 18 e acima · Homens · Atualizado em 15 de set. de 2026 · NCT07581184Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- XCancer Omaha LLC, Omaha
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 11 de set. de 2026 · NCT06056830Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Nebraska Medicine-Bellevue, Bellevue
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 10 de set. de 2026 · NCT05946213Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
- Research Site, Omaha
RecrutandoFase 1/2
Idades de 18 a 99 · Homens · Atualizado em 27 de ago. de 2026 · NCT07590934AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Research Site, Omaha
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 26 de ago. de 2026 · NCT07611110Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
- XCancer Omaha, Omaha
RecrutandoFase 2
Idades 18 e acima · Homens · Atualizado em 24 de ago. de 2026 · NCT07745361A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
- Nebraska Cancer Specialists, Omaha
RecrutandoFase 1/2
Idades 18 e acima · Homens · Atualizado em 20 de ago. de 2026 · NCT06785636Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- CHI Health Good Samaritan, Kearney
- Alegent Health Bergan Mercy Medical Center, Omaha
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 19 de ago. de 2026 · NCT04423211Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer
- University of Nebraska Medical Center, Omaha
RecrutandoFase 2
Idades 30 e acima · Homens · Atualizado em 19 de ago. de 2026 · NCT07237269Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- CHI Health Saint Francis, Grand Island
- CHI Health Good Samaritan, Kearney
- Alegent Health Immanuel Medical Center, Omaha
- e mais 2
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 14 de jul. de 2026 · NCT06592924Integrated Cancer Repository for Cancer Research
- Mary Lanning Healthcare, Morrison Cancer Center, Hastings
- Faith Regional Health Services, Carson Cancer Center, Norfolk
- Great Plains Regional Medical Center, North Platte
- e mais 3
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades de 19 a 110 · Todos os sexos · Atualizado em 29 de jun. de 2026 · NCT02012699Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
- Nebraska Cancer Specialists (Midwest Cancer Center - Legacy), Omaha
- XCancer Omaha / Urology Cancer Center, Omaha
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 11 de jun. de 2026 · NCT05283330Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
- Urology Cancer Center PC, Omaha
- Nebraska Cancer Specialists, Omaha
RecrutandoFase 4
Idades de 18 a 100 · Homens · Atualizado em 4 de jun. de 2026 · NCT05803941Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
- XCancer Omaha / Urology Cancer Center, Omaha
RecrutandoFase 1/2
Idades 18 e acima · Homens · Atualizado em 14 de mai. de 2026 · NCT05413850A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
- Research Site, Omaha
RecrutandoFase 1
Idades 18 e acima · Homens · Atualizado em 12 de mai. de 2026 · NCT06879041Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
- CHI Health Good Samaritan, Kearney
- Saint Elizabeth Regional Medical Center, Lincoln
- Alegent Health Immanuel Medical Center, Omaha
- e mais 4
RecrutandoFase 2
Idades 18 e acima · Homens · Atualizado em 29 de jan. de 2026 · NCT05806515Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
- Nebraska Medicine-Bellevue, Bellevue
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 22 de jan. de 2026 · NCT06470243High-dose Brachytherapy Boost With Stereostatic Body Radiation Therapy to Intermediate or Higher Risk Prostate Cancer
- University of Nebraska Medical Center, Omaha
Recrutando
Idades 19 e acima · Homens · Atualizado em 5 de nov. de 2025 · NCT05754580SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Omaha
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 28 de out. de 2025 · NCT03452774Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- Nebraska Medicine-Bellevue, Bellevue
- Nebraska Methodist Hospital, Omaha
- Nebraska Medicine-Village Pointe, Omaha
- e mais 1
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 11 de set. de 2025 · NCT03678025Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.